In one multicenter study, GLP-1 medicine use was associated with lower risks of major heart events, blood clots, kidney disease progression, and death compared with DPP-4 inhibitor medicines in patients with lupus and type 2 diabetes
Timing depends on diabetes status, baseline results, other medications, dose changes, kidney risk, gastrointestinal symptoms, and treatment goals
Other efficacy assessments include measurement of neck circumference, blood oxygen saturation and patientreported outcomes, as detailed below
The studies cited reflect current published research and do not guarantee specific outcomes
Mitochondria produce ATP, enabling stress adaptation for survival
Using slightly less strict parameters, we also identified a potential association between raised IGF-1 and increased risk for melanoma (skin cancer) and myeloma (cancer of the bone marrow)